MAM
GILD icon

Majedie Asset Management’s Gilead Sciences GILD Stock Holding History

Majedie Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-79,038
Closed -$5.01M – 85
2019
Q3 		$5.01M Sell
79,038
-4,034
-5% -$264K 0.43% 54
2019
Q2 		$5.62M Sell
83,072
-150,113
-64% -$9.88M 0.43% 49
2019
Q1 		$15.2M Sell
233,185
-4,325
-2% -$287K 1.07% 19
2018
Q4 		$15.2M Sell
237,510
-994
-0.4% -$69.5K 1.13% 21
2018
Q3 		$18.4M Sell
238,504
-17,436
-7% -$1.32M 1.39% 15
2018
Q2 		$18.1M Buy
255,940
+177,711
+227% +$12.5M 1.4% 14
2018
Q1 		$5.9M Buy
78,229
+24,488
+46% +$1.95M 0.54% 44
2017
Q4 		$3.85M Sell
53,741
-20,618
-28% -$1.57M 0.32% 58
2017
Q3 		$6.03M Sell
74,359
-27,701
-27% -$2.12M 0.49% 42
2017
Q2 		$7.22M Sell
102,060
-681
-0.7% -$45.3K 0.68% 37
2017
Q1 		$6.98M Sell
102,741
-1,573
-2% -$111K 0.75% 33
2016
Q4 		$7.47M Buy
104,314
+11,241
+12% +$836K 1% 24
2016
Q3 		$7.36M Buy
93,073
+129
+0.1% +$10.5K 1.18% 25
2016
Q2 		$7.75M Buy
92,944
+7,204
+8% +$639K 1.28% 23
2016
Q1 		$7.88M Sell
85,740
-5,080
-6% -$458K 1.16% 22
2015
Q4 		$9.19M Buy
90,820
+9,056
+11% +$942K 1.27% 19
2015
Q3 		$8.03M Buy
81,764
+31,235
+62% +$3.47M 1.24% 16
2015
Q2 		$5.92M Buy
50,529
+35,238
+230% +$3.85M 1.02% 15
2015
Q1 		$1.5M Buy
15,291
+2,102
+16% +$213K 0.34% 24
2014
Q4 		$1.24M Buy
13,189
+3,065
+30% +$317K 0.24% 25
2014
Q3 		$1.08M Buy
10,124
+4,450
+78% +$436K 0.18% 21
2014
Q2 		$470K Buy
+5,674
New +$442K 0.11% 21

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Majedie Asset Management's GILD Position: Q4 2019 in Review

Majedie Asset Management sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 79,038 shares — an estimated $5.01M sold.

Majedie Asset Management first reported a position in GILD in Q2 2014 and held it in 22 quarters. The position peaked at $18.4M in Q3 2018. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Majedie Asset Management reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
  • Majedie Asset Management sold 79,038 Gilead Sciences shares in Q4 2019, an estimated $5.01M.
  • Majedie Asset Management first reported a position in Gilead Sciences in Q2 2014 and held it in 22 quarters.
  • Majedie Asset Management's Gilead Sciences position peaked at $18.4M in Q3 2018.
  • 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Majedie Asset Management's 13F filing for Q4 2019, filed 7 Feb 2020.